ArticleFrontiers in immunology2020

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.

Peter van Balen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.